Perioperative Dexmedetomidine on Postoperative Delirium in Patients With Brain Tumors

NARecruitingINTERVENTIONAL
Enrollment

366

Participants

Timeline

Start Date

January 25, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Postoperative Delirium
Interventions
DRUG

Dexmedetomidine

In Dex group, dexmedetomidine will continue to be used during and after surgery, with a infusion of 0.4ug/kg/ h from anesthesia induction to dural closure, and then 0.08ug/kg/ h to 48 hours postoperatively.In placebo group, equivalent normal saline will be injected during operation, and the intravenous analgesia pump will not contain dexmedetomidine after operation

Trial Locations (1)

Unknown

RECRUITING

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER